These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24385684)

  • 21. Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans.
    Maccioni L; Kasavuli J; Leclercq S; Pirlot B; Laloux G; Horsmans Y; Leclercq I; Schnabl B; Stärkel P
    Hepatol Commun; 2023 May; 7(5):. PubMed ID: 37058088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pattern recognition receptor CD14 gene polymorphisms in alcohol use disorder patients and its Influence on liver disease susceptibility.
    Roy N; Nadda N; Kumar H; Prasad C; Kumar Jha J; Pandey HC; Vanamail P; Saraya A; Balhara YPS; Shalimar ; Nayak B
    Front Immunol; 2022; 13():975027. PubMed ID: 36238273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol?
    Bode C; Bode JC
    Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):166S-71S. PubMed ID: 16344604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative Stress Parameters in the Liver of Growing Male Rats Receiving Various Alcoholic Beverages.
    Kołota A; Głąbska D; Oczkowski M; Gromadzka-Ostrowska J
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31935882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease.
    Ceccarelli S; Nobili V; Alisi A
    World J Gastroenterol; 2014 Nov; 20(44):16443-51. PubMed ID: 25469012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The functional role of microRNAs in alcoholic liver injury.
    McDaniel K; Herrera L; Zhou T; Francis H; Han Y; Levine P; Lin E; Glaser S; Alpini G; Meng F
    J Cell Mol Med; 2014 Feb; 18(2):197-207. PubMed ID: 24400890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells.
    Petrasek J; Dolganiuc A; Csak T; Nath B; Hritz I; Kodys K; Catalano D; Kurt-Jones E; Mandrekar P; Szabo G
    Hepatology; 2011 Feb; 53(2):649-60. PubMed ID: 21274885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat.
    Nanji AA; Jokelainen K; Rahemtulla A; Miao L; Fogt F; Matsumoto H; Tahan SR; Su GL
    Hepatology; 1999 Oct; 30(4):934-43. PubMed ID: 10498645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocyte activation in alcoholic liver disease.
    McClain CJ; Hill DB; Song Z; Deaciuc I; Barve S
    Alcohol; 2002 May; 27(1):53-61. PubMed ID: 12062638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.
    Mandrekar P; Ambade A; Lim A; Szabo G; Catalano D
    Hepatology; 2011 Dec; 54(6):2185-97. PubMed ID: 21826694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin/interleukin-10/heme oxygenase-1 pathway.
    Mandal P; Pritchard MT; Nagy LE
    World J Gastroenterol; 2010 Mar; 16(11):1330-6. PubMed ID: 20238399
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Yeh WJ; Tsai CC; Ko J; Yang HY
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33353102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease.
    Petrasek J; Iracheta-Vellve A; Saha B; Satishchandran A; Kodys K; Fitzgerald KA; Kurt-Jones EA; Szabo G
    J Leukoc Biol; 2015 Aug; 98(2):249-56. PubMed ID: 25934928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ethanol changes sensitivity of Kupffer cells to endotoxin].
    Yamashina S; Ikejima K; Enomoto N; Takei Y; Sato N
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):415-24. PubMed ID: 14639920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?
    Seo W; Jeong WI
    World J Gastroenterol; 2016 Jan; 22(4):1348-56. PubMed ID: 26819504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptors in liver disease.
    Petrasek J; Csak T; Szabo G
    Adv Clin Chem; 2013; 59():155-201. PubMed ID: 23461136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease.
    Bautista AP
    J Gastroenterol Hepatol; 2000 Apr; 15(4):349-56. PubMed ID: 10824877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic effects of cytokine modulator Y-40138 in the rat alcoholic liver disease model.
    Kawaratani H; Tsujimoto T; Kitazawa T; Yoshiji H; Uemura M; Fukui H
    J Gastroenterol Hepatol; 2011 Apr; 26(4):775-83. PubMed ID: 21251062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Butyrate increases the monocytic myeloid-derived suppressor cells and promotes the secretion of anti-inflammatory cytokines in mice with alcoholic liver disease].
    Ren Y; Zhang X; He F; Bao T; Wang T; Li Y; Wang R; Wang H; Yang S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Oct; 38(10):865-871. PubMed ID: 36163616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances of sterile inflammation and inter-organ cross-talk in alcoholic liver disease.
    Shim YR; Jeong WI
    Exp Mol Med; 2020 May; 52(5):772-780. PubMed ID: 32457490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.